Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Septerna, Inc. - Common Stock (NQ:SEPN)

6.290 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 203
Open 6.290
Bid (Size) 5.530 (4)
Ask (Size) 10.06 (2)
Prev. Close 6.290
Today's Range 6.290 - 6.290
52wk Range 4.170 - 28.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results
From Septerna, Inc.
Via GlobeNewswire
SEPN Investors Have Opportunity to Join Septerna, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire

Performance

YTD
-70.5%
-70.5%
1 Month
-0.8%
-0.8%
3 Month
-62.9%
-62.9%
6 Month
-70.6%
-70.6%
1 Year
-70.6%
-70.6%

More News

Read More
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Septerna to Present at TD Cowen 45th Annual Health Care Conference
From Septerna, Inc.
Via GlobeNewswire
SEPTERNA ALERT: Bragar Eagel & Squire, P.C. is Investigating Septerna, Inc. on Behalf of Septerna Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Which stocks are moving on Tuesday?
Via Chartmill
Tuesday's session: gap up and gap down stocks
Via Chartmill
US Stocks Mixed; NY State Business Activity Rises In February
Via Benzinga
Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist
From Septerna, Inc.
Via GlobeNewswire
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer
From Septerna, Inc.
Via GlobeNewswire
Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Septerna, Inc.
Via GlobeNewswire
Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights
From Septerna, Inc.
Via GlobeNewswire
Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones
Via Benzinga
This Apollo Global Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Invizyne Technologies Jumps After IPO
Via Talk Markets
Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering
From Septerna, Inc.
Via GlobeNewswire
Ingram Micro Returns To Trading In Busy Week
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market

Frequently Asked Questions

Is Septerna, Inc. - Common Stock publicly traded?
Yes, Septerna, Inc. - Common Stock is publicly traded.
What exchange does Septerna, Inc. - Common Stock trade on?
Septerna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Septerna, Inc. - Common Stock?
The ticker symbol for Septerna, Inc. - Common Stock is SEPN on the Nasdaq Stock Market
What is the current price of Septerna, Inc. - Common Stock?
The current price of Septerna, Inc. - Common Stock is 6.290
When was Septerna, Inc. - Common Stock last traded?
The last trade of Septerna, Inc. - Common Stock was at 04/15/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.